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There is research evidence that exercise and motor training are beneﬁcial for people with Parkinson’s disease (PD), and clinicians
seek to implement optimal programs. This paper summarizes important factors about the nature and reporting of randomized
controlled trials of exercise and/or motor training for people with PD which are likely to inﬂuence the translation of research into
clinical practice. Searches identiﬁed 53 relevant trials with 90 interventions conducted for an average duration of 8.3 (SD 4.2)
weeks. Most interventions were fully supervised (74%) and conducted at a facility (79%). Retention rates were high with 69% of
interventions retaining ≥85% of their participants; however adherence was infrequently reported, and 72% of trials did not report
adverse events. Overall, the labor-intensive nature of most interventions tested in these trials and the sparse reporting of adherence
and adverse events are likely to pose diﬃculties for therapists attempting to balance beneﬁts and costs when selecting protocols
that translate to sustainable clinical practice for people with PD.
1.Introduction
In recent years there have been an increasing number of
randomized controlled trials assessing the eﬀects of exercise
and/or motor training in people with Parkinson’s disease
(PD). Overall, these trials support exercise and motor
training as beneﬁcial in improving walking, balance, muscle
strength, and the performance of functional tasks in people
withmild-to-moderatePD[1–11].Inorderforﬁndingsfrom
this research to be of general beneﬁt to people with PD, ther-
apists need to be able to translate the protocols used in the
research into clinical practice [12].
Evidence-based practice aims to incorporate and apply
high-quality clinical research ﬁndings in clinical policy and
practice [13, 14]. However, this can be a challenging task as
health practitioners may ﬁnd it diﬃcult to assess, interpret,
andimplementresearchevidence[13].Whileevidenceabout
beneﬁcial outcomes is paramount in therapists’ decisions to
implement a particular intervention, there are other factors
that aﬀect how the overall impact of the intervention is inter-
preted and its potential for widespread clinical application
[13–17]. For example, therapists need to consider how the
characteristics of participants included in a trial may aﬀect
their decision regarding the applicability of the trial inter-
vention with their patients [14]. It is likely that the way in
which the intervention was applied in terms of its duration,
level of supervision, delivery (i.e., individual versus group),
and location (e.g., facilities and equipment required) will
inﬂuence therapists’ decisions to implement that interven-
tion. A research protocol that has been shown to be eﬀective
may not be implemented by therapists if they cannot provide
adequatesupervisionovertherequiredtimeframeortheydo2 Parkinson’s Disease
not have access to necessary facilities or equipment. Finally,
information regarding retention, adherence, and adverse
eventsisrequiredsothattherapistsandpatientscanweighup
the eﬀectiveness of the intervention against its acceptability
and any risks associated with implementation [14].
Therefore, in order to examine the information available
to guide the translation of research into clinical practice,
we searched randomized controlled trials of exercise and/or
motor training for people with PD to determine the
(1) disease severity and cognitive status of the included
participants,
(2) duration, supervision, delivery, and location of the
interventions,
(3) rates of retention, adherence, and adverse events.
2. Methods
2.1.DataSourcesandSearches. Randomizedcontrolledtrials
of exercise and/or motor training for people with PD were
identiﬁed via database searches of MEDLINE, EMBASE,
AMED, PsycINFO, the Cochrane Central Register of Con-
trolledTrials,andCINAHL.Theinitialsearchwasconducted
in 2009, with a subsequent search conducted over 5 days
from the 7th of April, 2011. The electronic search strategy
used has been previously reported [2]. The Physiotherapy
Evidence Database (PEDro; http://www.pedro.org.au/)w a s
also searched, and the reference lists of previously published
systematic reviews [4, 5, 8, 9, 18–30]w e r ec h e c k e df o ra n y
trials not identiﬁed with the database search.
2.2. Study Selection. Trials included were published ran-
domized (or quasi randomized, i.e., not truly random but
intendedtoproducesimilargroups,suchasallocationbyodd
and even birth dates [31]) controlled trials of people with
PD where at least one of the interventions was an ongoing
program of exercise and/or motor training. All forms of
exercise (e.g., aerobic, strength, and treadmill walking) and
motortraining(e.g.,cueingandmovementstrategytraining)
were included. Whole-body vibration was not considered
to be exercise or motor training. Trials were excluded if
the intervention was multidisciplinary or was primarily
occupational therapy.
The eligibility of trials was determined in a two-stage
process. Firstly, all trial titles and abstracts were screened
i n d e p e n d e n t l yb yt w oi n v e s t i g a t o r s( N .E .A l l e na n dG .D .
Suriyarachchi). Trials were excluded if it was clear that they
did not meet the inclusion criteria. Secondly, the full article
was obtained for the remaining trials and each trial was
assessed independently by at least two investigators (N. E.
Allen, C. G. Canning or J. Song), using a standardized form
containingthedetailsoftheinclusioncriteria.Carewastaken
to identify trials that had been reported in more than one
journal article. Where this occurred, the multiple articles
were counted as one trial and all articles were used to collect
data for that trial.
2.3. Data Extraction. A data collection form was developed,
tested on ﬁve randomly selected trials and then modiﬁed
accordingly. All investigators were involved in data extrac-
tion, and all data was double-checked by an investigator not
involved in its initial extraction (N. E. Allen or J. Song).
Discrepancies were resolved by discussion.
Informationextractedfromeachtrialincludedadescrip-
tion of participants (including cognitive status), details of
the exercise and motor training program and how it was
administered, as well as details regarding retention rates,
adherencetotheintervention,andmonitoringandreporting
of adverse events. Retention was deﬁned as the number of
participants who completed the trial (i.e., undertook the
ﬁrst or only post-intervention assessment excluding further
follow-up assessments) expressed as a percentage of the
number of participants who began the trial. Adherence was
deﬁned as the number of intervention sessions attended by
participants expressed as a percentage of the number of
intervention sessions prescribed [15].
3. Results
Searching identiﬁed 3,539 records, of which 53 trials involv-
ing 1,940 participants were found to be eligible for inclusion
in the paper (Figure 1)[ 32]. There were no disagreements
betweenreviewersregardingtheinclusionofanyarticles.The
characteristics of the included trials [1, 3, 6, 7, 10, 11, 33–85]
are summarised in Table 1.
3.1. Participant Characteristics. Forty (75%) of the reviewed
trials included participants with mild-to-moderate PD (i.e.,
equivalent to Hoehn and Yahr stage I to III [86]). Seven
trials (13%) included participants with mild-to-moderately
severe PD (i.e., Hoehn and Yahr stage I to IV), while four
trials (8%) included only participants with mild PD and
two trials (4%) included only participants with moderate
PD (Table 1). Most trials stipulated the cognitive status of
included participants. Twenty-nine trials (55%) used the
Mini-Mental State Examination [87]t os c r e e np o t e n t i a l
participants’ cognitive abilities, with the minimum score for
inclusion varying between 20 and 28 out of the maximum
of 30 [1, 3, 6, 7, 10, 11, 34, 36, 39, 41–43, 45, 47–50, 56,
58, 60, 63–65, 69, 71, 76–78, 80, 85]. One trial (2%) [70]
speciﬁed that participants required at least moderate scores
ontheNeurobehaviouralCognitiveStatusExamination[88].
Thirteen trials (25%) made a statement to the eﬀect that
included participants had no dementia and/or reasonable
cognition[35,46,51,52,57,59,62,66,67,79,81,83,84].Ten
trials(19%)didnotgiveaclearindicationoftheparticipants’
cognitive abilities [33, 37, 40, 53, 55, 68, 72, 74, 75, 82].
3.2. Exercise and/or Motor Training Program Characteristics.
In the 53 trials, there were 90 intervention groups that
involved exercise and/or motor training (including two
intervention groups for the cross-over trials where one inter-
vention was a control [11, 42, 47]) (Table 1). Average inter-
vention duration was 8.3 weeks (SD = 4.2, range = 2t o2 6
weeks),with37trials(70%)conductinganinterventionof10
weeks or less. The total number of hours of intervention was
notclearlyreportedinallstudies(seeTable 1);however,from
the available data, an average of approximately 20 hours (SDParkinson’s Disease 3
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Figure 1: PRISMA ﬂow diagram [32] showing ﬂow of information through the review.
approximately 11, range = 4t o6 5h o u r s )a p p e a r sb r o a d l y
representative of the included trials. Sixty-seven of the
90 intervention groups (74%) involved full supervision of
exercise and/or motor training. Participants in 18 (27%) of
the fully supervised intervention groups received one-on-
one supervision and 20 (30%) received supervision in
small groups but the intervention delivery (one-on-one or
small group supervision) was unclear in the remaining 29
(43%)interventiongroups.Participantsinmostintervention
groups (71; 79%) were required to attend a facility for all or
the majority of the intervention sessions.
3.3. Retention, Adherence, and Adverse Events. Retention
was generally well reported and was high, with 62 (69%)
of the 90 intervention groups retaining at least 85% of
participants (Table 1). Seventeen (32%) of the 53 included
trials reported that at least one participant dropped out for
a reason related to the intervention (Table 2). Diﬃculties
with transport and disinterest/poor adherence were the most
common intervention-related reasons for dropouts.
Overall, adherence and adverse events were infrequently
reported in the included trials (Table 1). Adherence was
reported in some form in 26 (49%) of the included trials.
However, 11 (42%) of these trials only reported adherence
for those participants who completed the intervention. Most
trials(38;72%)didnotreportmonitoringforadverseevents.
Across the remaining 15 trials, 11 adverse events occurred
(Table 1). Four participants from two separate trials [41, 80]
experienced cardiac problems. Two of these participants,
one from each group in a trial comparing physical therapy
with and without mental practice [80], withdrew from the
study. The two participants from the other trial [41]w e r e
able to continue safely with treadmill training. Other adverse
events reported included a fall [81] and muscle cramps and
tiredness [43] in trials involving cued overground walking,
knee pain during a dancing program [52], muscle soreness4 Parkinson’s Disease
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Table 2: Dropout reasons when related to the intervention.
First author and year Dropout reason Number of
participants
Allen 2010 Did not want to do the intervention 1
Ashburn 2007 Falls (but not during intervention) 1
Blackinton 2002 Safety concerns 1
Braun 2011 Imagery too confronting 1
Burini 2006 Poor adherence to exercise; 2
back pain 1
de Bruin 2010 No access to necessary equipment 1
Dereli 2010 Did not want to do the intervention 1
Hackney 2008 (also as [54])
Exercise not intense enough; 1
transport problems 2
Hackney 2009 (also as [54])
Knee pain; 1
transport problems 2
Hackney 2010
Travel distance; 2
classes too fatiguing; 1
lack of interest 1
Hirsch 2003 Inguinal hernia 1
Kurtais 2008 Poor adherence to exercise 1
Sage 2009 Time commitment 4
Schmitz-Hubsch 2006 Uncomfortable in the group; 1
uncomfortable with Qigong 1
Smania 2010 Uncooperative 4
Stallibrass 2002 Could not travel 1
Yang 2010 Low motivation; 1
transport problems 1
and shoulder pain [56] following resistance training, and
a hernia [57] subsequent to muscle strength assessment.
4. Discussion
A substantial number of randomized controlled trials of
exercise and/or motor training for people with PD have
been published. However, the nature and reporting of these
trials are likely to provide challenges for therapists aiming to
implement the interventions into clinical practice [17]. Most
trials involved only cognitively intact participants with mild-
to-moderate PD.Trials tended tobe of short duration, highly
supervised, and conducted at a facility. Furthermore, the
reports for many trials were lacking important details, with
adherenceandadverseeventsparticularlybeinginadequately
reported.
On the whole, trials included in this paper included only
participants with mild-to-moderate PD who were without
signiﬁcant cognitive impairment. Including only these types
of participants not only makes it easier to conduct trials
of exercise and motor training interventions but also aids
interpretation of the results. However, cognitive impairment
is now recognised as a common problem in PD, with over
80% of people with PD ultimately developing dementia [89].
Further work is needed to determine the eﬀectiveness of
exercise and motor training in people with more severe
cognitive impairment and/or more advanced disease.
Most of the reviewed trials were of short duration, highly
supervised, and facility based (Table 1). Interventions lasted
an average of around two months. Seventy-four percent
of the intervention groups were fully supervised, with no
reported expectation for participants to undertake unsu-
pervised exercise. Furthermore, 79% of intervention groups
were mainly conducted at a facility such as a hospital or
university. Such brief, highly supervised interventions con-
ducted in controlled environments are likely to improve the
adherence of participants to exercise and motor training
programs and to ensure that interventions are being per-
formed optimally. In this regard, these trials are useful and
important for determining the short-term eﬃcacy of an
intervention. However, given that PD is a long-term, neu-
rodegenerative condition, the capacity of therapists and
patients to sustain the intervention over the long term
needs to be considered. Furthermore, such brief and highly
supervised interventions are costly and less likely to give12 Parkinson’s Disease
information about the eﬀectiveness of the intervention when
implemented into usual practice [13, 17]. For example, the
requirement for participants to travel to a facility was a
common reason for withdrawal from the included trials
(Table 2). Moreover, the neurodegenerative nature of PD
and the limited resources available to healthcare systems
mean that such labor-intensive programs are unlikely to
be sustained or aﬀorded by most health-care providers.
Additionally, as PD is a progressive disease it is important
that people with PD are empowered to self-manage their
disease to some extent [90, 91]. To this end, trials of
more pragmatic and sustainable exercise and motor training
interventions, with the potential for direct translation into
clinical practice and including cost-eﬀectiveness analysis, are
needed.
The likely adherence to an exercise and motor training
program is an important factor to consider when prescribing
such a program for an individual with PD. Adherence to the
intervention was reported in less than half of the included
trials, and some reports of adherence are artiﬁcially elevated
by including only those participants who completed the
trial (Table 1). Some trials were able to eﬀectively maximise
adherence by providing a ﬂexible timeframe for participants
to complete the intervention [46, 51, 52, 74, 76]a n ds o
allow participants more options in ﬁtting their exercise
and/or motor training program around their daily lives. This
pragmatic approach is likely to more closely reﬂect therapy
attendance patterns and is therefore likely to be helpful for
therapists considering translating the research into their
clinical practice.
Giventheimportanceofadherencetoexerciseandmotor
trainingprograms,strategiestopromoteadherenceinpeople
with PD need to be considered. Providing a high level of
supervision seems likely to promote adherence in the short
term, as it may enhance participants’ commitment to the
program. However, a Cochrane review comparing home and
centre-based exercise programs for older adults found that,
in the long term, participants were more likely to adhere to
home-based programs [92]. Furthermore, the reviewers
noted a trend toward more sustained improvements in the
home-based than in the centre-based programs and sug-
gested that this was attributable to the higher adherence in
home-based programs. In the present paper, three of the
included trials report high levels of adherence with mini-
mally supervised home-based programs [40, 43, 81]. Com-
mon to all three of these trials was a requirement for
participants to keep a daily record of what exercise/motor
training they had performed. It seems likely that this simple
strategy assisted in promoting adherence in these trials.
Other strategies with the potential to improve adherence in
sustainable, minimally supervised trials, such as participant
involvement in goal setting [93, 94], ﬂexibility to allow
programs to be modiﬁed for individuals [1, 91, 93, 94], and
intermittent followup [91, 94], warrant exploration.
Theissueofadverseeventswasinadequatelyaddressedin
the trials included in this paper, with only 15 trials reporting
monitoring for adverse events. In these 15 trials, 11 adverse
events were reported, most of which were minor in nature
(Table 1). However, when discussing and planning exercise
and motor training options with people with PD, therapists
need to be informed not only about the eﬀectiveness of a
given intervention but also about the nature and likelihood
of any potential adverse events [95]. Similarly poor reporting
of adverse events was found in a recent Cochrane review of
progressive resistance training for older adults [95]. Notably,
the Cochrane review found that adverse events were more
likely to be detected in trials that used a clear deﬁnition of
adverse events than in trials which did not use a deﬁnition.
In the same way, the use of a deﬁnition for adverse events
is likely to improve the assessment and reporting of adverse
events in trials of exercise and motor training for people with
PD.
Thispaperhasexaminedseveralfactorsinthenatureand
reporting of trials of exercise and/or motor training which
arelikelytoinﬂuencethewayresearchisappliedbytherapists
in clinical practice. However, this paper did not address
whether or not trial protocols were reported in suﬃcient
detailtoallowtherapiststoemulatetheresearchintervention
in the clinic. This detailed reporting of trial interventions is
critical in enabling research to be clinically applied [96]. The
ability of many journals to provide online material which
supplements the published article will aid the provision of
such details despite the necessary word count limitations
placed on authors.
5. Conclusions
Clinicians seeking to use research to inform their clinical
practice rely heavily on the design and reporting of ran-
domized controlled trials to reach their decisions. However,
the nature and reporting of trials of exercise and/or motor
training for people with PD are likely to provide challenges
for therapists aiming to implement the interventions into
clinical practice. The short duration, highly supervised and
facility-based nature of many of the interventions, coupled
with the tendency to include only cognitively-intact partic-
ipants with mild-to-moderate disease, mean that ﬁndings
may not generalise when therapists set out to apply them in
the long-term management of people with PD. Infrequent
reporting of adherence and adverse events compounds this
problem and makes cost-beneﬁt balancing more diﬃcult. It
is recommended that these issues be taken into account in
the design and reporting of future trials.
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